Revolution Medicines, Inc. (RVMD)
147.01
+10.71
(+7.86%)
USD |
NASDAQ |
Apr 14, 16:00
148.31
+1.30
(+0.88%)
After-Hours: 05:13
Revolution Medicines EPS Diluted (Quarterly) : -1.855 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| Tango Therapeutics, Inc. | -0.2945 |
| AbbVie, Inc. | 1.018 |
| AtriCure, Inc. | 0.0366 |
| Insmed, Inc. | -1.538 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -364.89M |
| Total Expenses (Quarterly) | 364.89M |
| Enterprise Value | 27.53B |
| Earnings Yield | -4.02% |
| Normalized Earnings Yield | -3.987 |